Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

ClinicalTrials.gov ID: NCT06502366

Public ClinicalTrials.gov record NCT06502366. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-controlled, Double-blind, Multicenter, 12-Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared With BDA Delivered by MDI HFA in Participants With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed replacement propellant HFO compared with BDA delivered using the currently approved propellant HFA in participants with asthma.

Study identification

NCT ID
NCT06502366
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
422 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 21, 2024
Primary completion
Mar 2, 2026
Completion
Mar 2, 2026
Last update posted
Feb 12, 2026

2024 – 2026

United States locations

U.S. sites
70
U.S. states
31
U.S. cities
69
Facility City State ZIP Site status
Research Site Mobile Alabama 36608
Research Site Sheffield Alabama 35660
Research Site Phoenix Arizona 85018
Research Site Little Rock Arkansas 72205
Research Site Encinitas California 92024
Research Site Fullerton California 92835
Research Site Gardena California 90247
Research Site Huntington Beach California 92647
Research Site La Mesa California 91942
Research Site Los Angeles California 90025
Research Site Los Angeles California 90048
Research Site Sacramento California 95821
Research Site San Bernardino California 92408
Research Site San Diego California 92123
Research Site San Jose California 95117
Research Site Santa Ana California 92704
Research Site Stockton California 95207
Research Site Westminster California 92683
Research Site Englewood Colorado 80110
Research Site Wheat Ridge Colorado 80033
Research Site Washington D.C. District of Columbia 20016
Research Site Boynton Beach Florida 33435
Research Site Miami Florida 33175
Research Site Tallahassee Florida 32308
Research Site Tampa Florida 33607
Research Site Atlanta Georgia 30328
Research Site Rincon Georgia 31326
Research Site Savannah Georgia 31406
Research Site Meridian Idaho 83646
Research Site River Forest Illinois 60305
Research Site Evansville Indiana 47715
Research Site Valparaiso Indiana 46383
Research Site Sioux City Iowa 51106
Research Site Louisville Kentucky 40217
Research Site Lafayette Louisiana 70508
Research Site New Orleans Louisiana 70119
Research Site White Marsh Maryland 21162
Research Site Flint Michigan 48504
Research Site Columbia Missouri 65203
Research Site St Louis Missouri 63141
Research Site Omaha Nebraska 68134
Research Site Monticello New York 12701
Research Site New York New York 10036
Research Site Watertown New York 13601
Research Site Charlotte North Carolina 28273
Research Site Raleigh North Carolina 27607
Research Site Cincinnati Ohio 45236
Research Site Oklahoma City Oklahoma 73120
Research Site Tulsa Oklahoma 74136
Research Site Medford Oregon 97504
Research Site Portland Oregon 97202
Research Site Pottstown Pennsylvania 19464
Research Site Scottdale Pennsylvania 15683
Research Site Greenville South Carolina 29615
Research Site North Charleston South Carolina 29420
Research Site Boerne Texas 78006
Research Site Dallas Texas 75231
Research Site DeSoto Texas 75115
Research Site El Paso Texas 79924
Research Site Kingwood Texas 77339
Research Site McKinney Texas 75069
Research Site Pearland Texas 77584
Research Site San Antonio Texas 78258
Research Site Victoria Texas 77901
Research Site West Jordan Utah 84088
Research Site Burke Virginia 22015
Research Site Portsmouth Virginia 23703
Research Site Spokane Washington 99218
Research Site Morgantown West Virginia 26505
Research Site Milwaukee Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06502366, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06502366 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →